These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 22820159)
1. Identifying leukemia stem cells--is it feasible and does it matter? Lutz C; Hoang VT; Buss E; Ho AD Cancer Lett; 2013 Sep; 338(1):10-4. PubMed ID: 22820159 [TBL] [Abstract][Full Text] [Related]
2. Leukemia stem cells. Buss EC; Ho AD Int J Cancer; 2011 Nov; 129(10):2328-36. PubMed ID: 21796620 [TBL] [Abstract][Full Text] [Related]
3. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance. Hoang VT; Zepeda-Moreno A; Ho AD Biotechnol J; 2012 Jun; 7(6):779-88. PubMed ID: 22588704 [TBL] [Abstract][Full Text] [Related]
4. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients. Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165 [TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Cheung AM; Wan TS; Leung JC; Chan LY; Huang H; Kwong YL; Liang R; Leung AY Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279 [TBL] [Abstract][Full Text] [Related]
6. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118 [TBL] [Abstract][Full Text] [Related]
7. Acute myelogenous leukemia stem cells: from Bench to Bedside. Felipe Rico J; Hassane DC; Guzman ML Cancer Lett; 2013 Sep; 338(1):4-9. PubMed ID: 22713929 [TBL] [Abstract][Full Text] [Related]
8. Selective elimination of leukemia stem cells: hitting a moving target. Crews LA; Jamieson CH Cancer Lett; 2013 Sep; 338(1):15-22. PubMed ID: 22906415 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms controlling pathogenesis and survival of leukemic stem cells. Jordan CT; Guzman ML Oncogene; 2004 Sep; 23(43):7178-87. PubMed ID: 15378078 [TBL] [Abstract][Full Text] [Related]
10. Identification and separation of normal hematopoietic stem cells and leukemia stem cells from patients with acute myeloid leukemia. Hoang VT; Hoffmann I; Borowski K; Zepeda-Moreno A; Ran D; Buss EC; Wuchter P; Eckstein V; Ho AD Methods Mol Biol; 2013; 1035():217-30. PubMed ID: 23959995 [TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes. Ran D; Schubert M; Pietsch L; Taubert I; Wuchter P; Eckstein V; Bruckner T; Zoeller M; Ho AD Exp Hematol; 2009 Dec; 37(12):1423-34. PubMed ID: 19819294 [TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Hope KJ; Jin L; Dick JE Nat Immunol; 2004 Jul; 5(7):738-43. PubMed ID: 15170211 [TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095 [TBL] [Abstract][Full Text] [Related]
15. Normal and leukaemic stem cells. Bonnet D Br J Haematol; 2005 Aug; 130(4):469-79. PubMed ID: 16098060 [TBL] [Abstract][Full Text] [Related]
16. Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. Giuntoli S; Rovida E; Gozzini A; Barbetti V; Cipolleschi MG; Olivotto M; Dello Sbarba P Stem Cells; 2007 May; 25(5):1119-25. PubMed ID: 17255519 [TBL] [Abstract][Full Text] [Related]